Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mollee

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Hospital Infection|October 17, 2021
Catheter-associated bloodstream infection in patients with cancer: comparison of left- and right-sided insertionsM Jones, S Okano, D Looke, et al.
The Journal of Hospital Infection|July 27, 2020
Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trialP Mollee, S Okano, E Abro, et al.
Blood Cancer Journal|January 14, 2014
Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndromeP Tan, A Wei, S Mithraprabhu, et al.
British Journal of Haematology|April 21, 2018
Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvementC K Chin, E Tsang, H Mediwake, et al.
Internal Medicine Journal|March 5, 2015
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Internal Medicine Journal|January 14, 2015
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2015
International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trialR U Trappe, S Choquet, D Dierickx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Hospital Infection|October 17, 2021
Catheter-associated bloodstream infection in patients with cancer: comparison of left- and right-sided insertionsM Jones, S Okano, D Looke, et al.
The Journal of Hospital Infection|July 27, 2020
Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trialP Mollee, S Okano, E Abro, et al.
Blood Cancer Journal|January 14, 2014
Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndromeP Tan, A Wei, S Mithraprabhu, et al.
British Journal of Haematology|April 21, 2018
Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvementC K Chin, E Tsang, H Mediwake, et al.
Internal Medicine Journal|March 5, 2015
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Internal Medicine Journal|January 14, 2015
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupH Quach, D Joshua, J Ho, et al.
Internal Medicine Journal|August 30, 2014
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupN Weber, P Mollee, B Augustson, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2015
International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trialR U Trappe, S Choquet, D Dierickx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.
Pageof 4